Data on the association of serum glypican-4 with prevalent and future kidney function

Published: 11 February 2022| Version 1 | DOI: 10.17632/nx94z23388.1
Contributors:
Axel Muendlein,
,
,
,
,
,
,
,
,

Description

The present study included 456 patients who were referred to elective coronary angiography. Serum GPC4 levels were measured with a commercially available ELSIA kit. Glomerular filtration rate (GFR) was estimated (eGFR) using the ‘Chronic Kidney Disease Epidemiology Collaboration’ (CKD-EPI) serum creatinine equation. GFR categories were defined as follows: G1: eGFR≥90 mL/min/1.73 m2; G2: eGFR=60-89 mL/min/1.73 m2; G3a: eGFR=45-59 mL/min/1.73 m2; G3b: eGFR=30-44 mL/min/1.73 m2; G4: eGFR=15-29 mL/min/1.73 m2. Urinary albumin excretion was expressed as ACR in a random morning urine specimen. ACR levels lower than 30 mg/g (category A1) were defined as normal and albuminuria was diagnosed as an ACR of 30 mg/g or greater. CKD was diagnosed in case of eGFR ˂ 60 mL/min/1.73 m2 or albuminuria. After a mean period of 3.5 years, patients were re-invited to undergo a follow-up investigation and kidney function was reassessed. The Table includes baseline characteristics and GPC4 values as well as parameters of kidney function.

Files

Categories

Biomarkers, Risk Factor, Prospective Study, Kidney, Chronic Kidney Disease, Glomerular Filtration Rate

Licence